Living Biotech Nutrition Supplement LCP051

• Customization: Available
• CAS No.: N
• Formula: N
• Model NO.: LCP
• Packaging Material: Plastic
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Protein
• Resource: Natural
• The content of active substances: 31%~60%
• Smell: Addible
• Appearance: Multiple
• Transport Package: Carton
• Specification: TBC
• Trademark: N
• Origin: China
• HS Code: 21069090
• Production Capacity: 8, 000kg/M

Product Description

Introducing
Lactobacillus crispatus is the dominant species in the vaginal microbiota associated with health and considered a homeostasis biomarker. Interestingly, some strains are even used as probiotics. However, the genetic mechanisms of L. crispatus involved in the control of the vaginal microbiome and protection against bacterial vaginosis (BV) are not entirely known. To further investigate these mechanisms, we sequenced and characterized the first four L. crispatus genomes from vaginal samples from Brazilian women and used genome-wide association study (GWAS) and comparative analyses to identify genetic mechanisms involved in healthy or BV conditions and selective pressures acting in the vaginal microbiome. 
The vaginal microbiota of reproductive-age women is classified into at least five types called community state types (CST). Four of them are dominated by Lactobacillus crispatus (CST-I), L. gasseri (CST-II), L. iners (CST-III), or L. jensenii (CST-V). The CST-IV is characterized as having a significantly lower number of lactobacilli and an increased number and diversity of strict and facultative anaerobes (Ravel et al., 2011). The lactobacilli use the glycogen supplied by the host as a carbon source and create a protective environment against infections or colonization by pathogens and non-indigenous microbes by the production of L- and/or D-lactic acid, bacteriocins, hydrogen peroxide, competition for tissue adhesion, enhancement of the protective mucus layer integrity and modulation of the innate immune system response.

The approaches to treating various vaginal infections. Pathogens associated with BV, VVC, AV, viral infections, and other STIs can cause damage to vaginal epithelial cells and mucosa. Approaches including antibiotics, probiotics, and antibiotics plus probiotics could affect therapeutic efficacy.
Dosage
Pls follow physician's guidanve or instructions enclosed. 
Storage
Better at 5-15 DC and keep dry in dark.
More;